Listed
SME IPO
KRMAYURVEDA
KRM Ayurveda
KRM Ayurveda IPO ke live GMP, listing timeline, price band, subscription momentum aur key issue details yahan track karein.
IPO Details
Complete IPO information
| Current GMP |
₹37.1 |
| Estimated Listing Gain |
+27.48% |
| Price Band |
₹128.00 - ₹135.00 |
| Issue Price |
₹135.00 |
| Listing Price |
₹172.10 |
| Lot Size |
1,000 Shares |
| Issue Type |
SME |
| Issue Size |
TBA |
| Registrar |
TBA |
| Exchange |
NSE, BSE |
| Retail Quota |
TBA |
| Overall Subscription |
TBA |
| Listing Date |
29 Jan 2026 |
| Minimum Investment |
₹2,70,000 |
Timeline
IPO roadmap at a glance
01
Bidding Opens
21 Jan 2026
02
Bidding Closes
23 Jan 2026
Grey Market Premium
Daily GMP status
| Date |
GMP |
Change |
Gain |
| 29 Jan 2026 |
₹23.00 |
+₹4.50
|
17.04% |
| 27 Jan 2026 |
₹18.50 |
+₹2.50
|
13.70% |
| 26 Jan 2026 |
₹16.00 |
+₹4.00
|
11.85% |
| 22 Jan 2026 |
₹12.00 |
-₹9.00
|
8.89% |
| 21 Jan 2026 |
₹21.00 |
+₹1.00
|
15.56% |
| 19 Jan 2026 |
₹20.00 |
+₹5.00
|
14.81% |
| 16 Jan 2026 |
₹15.00 |
-
|
11.11% |
Market Lot
Application size breakdown
| Category |
Lots |
Shares |
Amount |
| Retail Minimum |
2 Lot |
2,000 |
₹2,70,000 |
| Retail Maximum |
2 Lot |
2,000 |
₹2,70,000 |
| S-HNI Minimum |
3 Lot |
3,000 |
₹4,05,000 |
| S-HNI Maximum |
7 Lot |
7,000 |
₹9,45,000 |
| B-HNI Minimum |
8 Lot |
8,000 |
₹10,80,000 |
Analysis
KRM Ayurveda IPO – Key Details
| IPO Open Date |
January 21, 2026 |
| IPO Close Date |
January 23, 2026 |
| Face Value |
₹10 per Equity Share |
| Price Band |
₹128 – ₹135 per Share |
| Issue Size |
Approx ₹77 Crores |
| Fresh Issue |
Approx ₹77 Crores |
| Issue Type |
Book Build Issue |
| IPO Listing |
NSE SME |
Analysis
KRM Ayurveda IPO – Market Lot Details
| Application |
Lot Size |
Shares |
Amount (₹) |
| Retail Minimum |
2 |
2,000 |
2,70,000 |
| Retail Maximum |
2 |
2,000 |
2,70,000 |
| S‑HNI Minimum |
3 |
3,000 |
4,05,000 |
| S‑HNI Maximum |
7 |
7,000 |
9,45,000 |
| B‑HNI Minimum |
8 |
8,000 |
10,80,000 |
Analysis
KRM Ayurveda IPO – Reservation Details
| Investor Category |
Shares Offered |
Percentage (%) |
| Anchor Investor |
15,87,000 |
27.65% |
| QIB (Ex. Anchor) |
10,62,000 |
18.50% |
| NII |
8,01,000 |
13.95% |
| Retail |
18,66,000 |
32.51% |
Analysis
KRM Ayurveda IPO – Anchor Investors
| Anchor Bidding Date |
January 20, 2026 |
| Anchor Investors List |
– |
| Shares Offered to Anchor Investors |
15,87,000 Shares |
| Anchor Size |
– |
| Lock‑in Period (50% Shares – 30 Days) |
February 26, 2026 |
| Lock‑in Period (50% Shares – 90 Days) |
April 27, 2026 |
Analysis
KRM Ayurveda IPO – Important Dates
| IPO Open Date |
January 21, 2026 |
| IPO Close Date |
January 23, 2026 |
| Basis of Allotment |
January 27, 2026 |
| Refunds Initiation |
January 28, 2026 |
| Credit to Demat Account |
January 28, 2026 |
| IPO Listing Date |
January 29, 2026 |
| IPO Bidding Cut‑off Time |
January 23, 2026 – 5:00 PM |
Analysis
KRM Ayurveda IPO – Promoters & Holding Pattern
Promoters: Mr. Puneet Dhawan and Mrs. Tanya Dhawan
| Particulars |
Shares |
Shareholding (%) |
| Promoter Holding (Pre‑Issue) |
1,55,20,800 |
92.16% |
| Promoter Holding (Post‑Issue) |
2,12,60,800 |
67.28% |
Analysis
KRM Ayurveda IPO – Objects of the Issue & Utilisation of Proceeds
| Purpose |
Amount (₹ Cr) |
| Capital Expenditure for construction and development of Telemedicine operational facilities |
13.67 |
| Purchase of CRM software and hardware infrastructure |
1.42 |
| Human Resources |
5.44 |
| Repayment / Prepayment of loan |
12.50 |
| Working Capital Requirement |
18.00 |
| General Corporate Purpose |
– |
Analysis
About KRM Ayurveda IPO
KRM Ayurveda Ltd started its journey on 3 September 2019, with the work of manufacturing Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items.
The company has many hospitals and clinics across India, not only in India, but it also provides telemedicine services and sales abroad. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. The company has good services for the patient, including In-Patient & Out-Patient Care, Panchakarma Therapies, Specialized Clinics, Medicinal Sales, Diet & Lifestyle Counseling.
Strengths:
- Skilled Ayurvedic doctors and trained therapists ensure quality treatment.
- The company is a trusted brand with loyal and repeat customers.
Analysis
KRM Ayurveda IPO – Company Financial Report
| Period Ended |
Revenue (₹ Cr) |
Expense (₹ Cr) |
PAT (₹ Cr) |
Assets (₹ Cr) |
| FY 2023 |
89.38 |
79.29 |
7.60 |
39.48 |
| FY 2024 |
67.57 |
62.85 |
3.41 |
43.91 |
| FY 2025 |
76.95 |
60.61 |
12.10 |
66.79 |
| Sep 2025 |
48.65 |
37.65 |
8.14 |
78.12 |
Analysis
KRM Ayurveda IPO – Valuation (FY2025)
| KPI |
Values |
| ROE |
67.86% |
| ROCE |
43.33% |
| EBITDA Margin |
24.96% |
| PAT Margin |
15.80% |
| Debt to Equity Ratio |
1.31 |
| Earning Per Share (EPS) |
₹8.06 (Basic) |
| Price / Earnings (P/E) |
N/A |
| Return on Net Worth (RoNW) |
67.86% |
| Net Asset Value (NAV) |
₹1,602.40 |
Analysis
KRM Ayurveda IPO – Peer Group Comparison
| Company |
EPS (₹) |
P/E Ratio |
RoNW (%) |
NAV (₹) |
Income (₹ Cr) |
| Jeena Sikho Lifecare Ltd. |
8.86 |
76.58 |
31.28% |
142.24 |
110.10 |
| Vaidya Sane Ayurved Laboratories Ltd. |
3.07 |
93.20 |
5.12% |
59.85 |
3.22 |